FDA moves toward easing restrictions on certain peptides BioPharma Dive Understanding the Legal Risks of BPC 157 and Other Unapproved Peptides Holt Law FDA Moves on Peptides: What Compounding Pharmacies Need to Know Peptides take off as a DIY treatment but is that a good idea? : NPR BPC 157 and ipamorelin under FDA scrutiny Alex Keoskey posted on the topic LinkedIn We have received an uptick in questions related to this substance. We felt it was best to share our policy here to bring attention to it. . OCB adheres to WADA guidelines